Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells

Citation
L. Vernhet et al., Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells, FEBS LETTER, 443(3), 1999, pp. 321-325
Citations number
24
Categorie Soggetti
Biochemistry & Biophysics
Journal title
FEBS LETTERS
ISSN journal
00145793 → ACNP
Volume
443
Issue
3
Year of publication
1999
Pages
321 - 325
Database
ISI
SICI code
0014-5793(19990129)443:3<321:OOTMRP>2.0.ZU;2-Y
Abstract
Cellular and molecular mechanisms involved in the resistance to cytotoxic h eavy metals remain largely to be characterized in mammalian cells. To this end, we have analyzed a metal-resistant variant of the human lung cancer GL C4 cell line that we have selected by a step-wise procedure in potassium an timony tartrate. Antimony-selected cells, termed GLC4/Sb30 cells, poorly ac cumulated antimony through an enhanced cellular efflux of metal, thus sugge sting up-regulation of a membrane export system in these cells. Indeed, GLC 4/Sb30 cells were found to display a functional overexpression of the multi drug resistance-associated protein MRP1, a drug export pump, as demonstrate d by Western blotting, reverse transcriptase-polymerase chain reaction and calcein accumulation assays, Moreover, MK571, a potent inhibitor of MRP1 ac tivity, was found to markedly down-modulate resistance of GLC4/Sb30 cells t o antimony and to decrease cellular export of the metal. Taken together, ou r data support the conclusion that overexpression of functional MRP1 likely represents one major mechanism by which human cells can escape the cytotox ic effects of heavy metals. (C) 1999 Federation of European Biochemical Soc ieties.